Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.
Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback